Alerts will be sent to your verified email
Verify Email
VILINBIO
|
Vilin Bio Med
|
Mangalam Drugs&Org.
|
Vista Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.09 % | 1.78 % | 0.0 |
|
5yr average Equity Multiplier
|
1.6 | 2.43 | 1.42 |
|
5yr Average Asset Turnover Ratio
|
0.68 | 1.0 | 0.08 |
|
5yr Avg Net Profit Margin
|
2.8 % | 0.0 | -205.63 % |
|
Price to Book
|
2.04 | 0.37 | 1.03 |
|
P/E
|
210.97 | 0.0 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
211.9 Days | 17.41 Days | 124.89 Days |
|
Inventory Days
|
70.76 Days | 132.58 Days | 3040.44 Days |
|
Days Receivable
|
147.75 Days | 38.43 Days | 137.33 Days |
|
Days Payable
|
44.01 Days | 126.53 Days | 1845.08 Days |
|
5yr Average Interest Coverage Ratio
|
1.77 | 0.9 | -2.88 |
|
5yr Avg ROCE
|
8.99 % | 6.92 % | -8.17 % |
|
5yr Avg Operating Profit Margin
|
9.07 % | 7.63 % | -192.46 % |
|
5 yr average Debt to Equity
|
0.47 | 0.59 | 0.26 |
|
5yr CAGR Net Profit
|
12.89 % | 39.54 % | 19.73 % |
|
5yr Average Return on Assets
|
1.89 % | -0.18 % | -6.49 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.65 % | 35.64 % | 21.19 % |
|
Share Pledged by Promoters
|
0.0 | 7.09 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.87 % | -14.68 % | -14.25 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | -0.02 % |
|
Vilin Bio Med
|
Mangalam Drugs&Org.
|
Vista Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|